Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimzox MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Mblaze Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimzox MV 2mg/500mg/0.2mg Tablet

Diabex Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Diabex Trio should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol should be avoided due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimzox MV 2mg/500mg/0.2mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Glimzox MV 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimzox MV 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Glimzox MV 2mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Glimzox MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimzox MV 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimzox MV 2mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.

How Glimzox MV 2mg/500mg/0.2mg Tablet works:

Tri-action Glycemic Control Tablet (Glimzox MV 2mg/500mg/0.2mg) combines three antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimzox MV 2mg/500mg/0.2mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnant individuals should exercise caution when considering Glimzox MV 2mg/500mg/0.2mg Tablets. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the treatment's advantages against possible risks prior to prescription. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimzox MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Glimzox MV 2mg/500mg/0.2mg tablets in individuals with kidney impairment carries a significant risk and is best avoided. Medical advice is crucial before use. Furthermore, the use of Glimzox MV 2mg/500mg/0.2mg tablets is contraindicated for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimzox MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In individuals with mild to moderate hepatic dysfunction, a low initial dose is typically prescribed; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimzox MV 2mg/500mg/0.2mg Tablet :

Should you forget to take your Glimzox MV 2mg/500mg/0.2mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimzox MV 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimzox MV 2mg/500mg/0.2mg Tablet

Glimzox MV 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is unsuitable for type 1 DM.
Glimzox MV 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Glimzox MV 2mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimzox MV 2mg/500mg/0.2mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimzox MV 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication, tightly sealed, in its original packaging. Follow the storage instructions on the package or label. Discard any unused medication; keep it out of reach of children, pets, and others.
Glimzox MV 2mg/500mg/0.2m...
143
MRP 165
13% off